Target intelligence / Profile preview

Multidrug-binding transcriptional repressor QacR (QacR)

Target
QacR
Molecular classification
Transcription factor, TetR family regulator, DNA-binding protein
01

Overview

The Multidrug-binding transcriptional repressor QacR is a member of the TetR family of transcriptional regulators, primarily found in Staphylococcus aureus. It plays a critical role in bacterial multidrug resistance by regulating the expression of the qacA gene, which encodes a major multidrug efflux pump (Schumacher et al., 2001). QacR is distinguished by its ability to recognize and bind an exceptionally broad range of structurally diverse cationic lipophilic compounds, including common antiseptics like chlorhexidine and dyes like crystal violet (Grkovic et al., 2003). Under normal conditions, QacR binds as a pair of dimers to the IR1 operator DNA, sterically hindering RNA polymerase and repressing transcription. When a ligand binds to the expansive, multisite binding pocket of QacR, it triggers a coil-to-helix conformational change that causes the protein to dissociate from the DNA, thereby inducing the expression of the QacA pump and facilitating the efflux of toxic agents (Schumacher et al., 2002). This mechanism makes QacR a significant target for research aimed at overcoming antibiotic resistance in pathogenic bacteria.

Other names
HTH-type transcriptional regulator QacRQacR repressorStaphylococcus aureus QacRMultidrug resistance protein R
02

Mechanism of action

QacR acts as a transcriptional repressor that binds to the operator of the qacA gene; ligand binding induces a conformational change that releases the repressor from DNA, allowing transcription of the multidrug efflux pump.

03

Biological functions

Regulation of gene expressionSensing of toxic compoundsBacterial stress responseTranscriptional repression
04

Disease associations

Bacterial infectionMultidrug resistance (MDR)Staphylococcal infection
05

Safety considerations

Broad ligand specificity complicates the design of specific inhibitorsRisk of unintended induction of resistance mechanismsChallenges in delivering therapeutic agents across the bacterial cell envelope
06

Interacting drugs

Rhodamine 6G

8 more in the full profile.

07

Biomarkers

qacR gene presenceqacA mRNA expression levelsPresence of qacA-qacR locus in clinical isolates

Beyond the preview

Go deeper on Multidrug-binding transcriptional repressor QacR (QacR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multidrug-binding transcriptional repressor QacR (QacR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call